Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Research shows that most adults who stop a GLP-1 medication regain at least some of their weight in the year after stopping the medication, with one study showing an average regain of two-thirds of their previous weight loss
Weight Loss Up to ~21% reduction Sustained at 72 weeks Beats GLP-1 alone Glycemic Control Lower HbA1c Steadier blood sugar GIP boosts response Cardiometabolic Lower blood pressure Better lipid panel Trial signals on CV Appetite Control Quieter cravings Smaller portions Less food noise Lose more weight on your terms
Zydus Lifesciences: has a novel pipeline that includes Saroglitazar , which is in Phase II/b trials in the US for NASH (non-alcoholic steatohepatitis), a condition often associated with obesity and metabolic dysfunction
Recent research from the National Institutes of Health (NIH) has highlighted that while GLP-1 medications are effective for weight management and blood sugar control, understanding their impact on nutrient absorption is crucial [1]
Together, these nutrients help maintain healthy glutathione (GSH) levels and enhance the bodys overall antioxidant defense system
Clinical studies reveal average weight reductions between 15% and 20% when paired with lifestyle adjustments
